Ramsay RR et al., 2007-08-27: Kinetic study with purified human monoamine oxidase showing methylene blue is a potent, tight-binding reversible inhibitor of MAO-A and a weaker inhibitor of MAO-B, which would perturb serotonin metabolism.
MB is a potent reversible inhibitor of MAO A with implications for gut uptake of amines when administered orally.
Ramsay RR et al., 2007-08-27: Kinetic study with purified human monoamine oxidase showing methylene blue is a potent, tight-binding reversible inhibitor of MAO-A and a weaker inhibitor of MAO-B, which would perturb serotonin metabolism. Study type: in vitro enzymology (purified human MAO A and MAO B), not a clinical study. N: not applicable. Country: UK (St Andrews) and Australia (PsychoTropical Research). Dose: not applicable; concentrations 1-30 microM in assays. Funder/conflicts not stated in abstract. Relevance to C8: establishes the actual monoamine mechanism (reversible MAO-A inhibition, i.e. reduced degradation of serotonin and other amines), not 'enhanced production' of serotonin or dopamine. Full text also available at PMC2078225. Also filed as MTC-107, MTO-05, MTJ-19 (claims C1, C4, C8, F3). Study type: lab.
